Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
第一作者:
L,Keyvani
第一单位:
Section of Gastroenterology, Department of Internal Medicine, University of Manitoba, 804E-715 McDermot Avenue, Winnipeg, Manitoba, Canada.
作者:
医学主题词
2-吡啶甲基亚硫酰苯咪唑类(2-Pyridinylmethylsulfinylbenzimidazoles);急性病(Acute Disease);投药, 口服(Administration, Oral);老年人(Aged);老年人, 80以上(Aged, 80 and over);药物疗法, 联合(Drug Therapy, Combination);内窥镜检查, 胃肠道(Endoscopy, Gastrointestinal);酶抑制剂(Enzyme Inhibitors);女(雌)性(Female);胃肠出血(Gastrointestinal Hemorrhage);组胺H2拮抗剂(Histamine H2 Antagonists);人类(Humans);输注, 静脉内(Infusions, Intravenous);注射, 静脉内(Injections, Intravenous);男(雄)性(Male);中年人(Middle Aged);奥美拉唑(Omeprazole);质子泵抑制剂(Proton Pump Inhibitors);复发(Recurrence);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)
DOI
10.1111/j.1365-2036.2006.03115.x
PMID
17014584
发布时间
2018-12-01
- 浏览18
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



